Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells

Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells

Immunotherapy targeting glioblastoma initiating cells (GIC) is considered a promising strategy. However, GIC are prone to evade immune response and there is a need for potent adjuvants. IFN-β might enhance the immune response and here we define its net effect on the innate immunogenicity of GIC. The...

Full description

Bibliographic Details
Main Authors: Wolpert, Fabian, Happold, Caroline, Reifenberger, Guido, Florea, Ana-Maria, Deenen, René, Roth, Patrick, Neidert, Marian Christoph, Lamszus, Katrin, Westphal, Manfred, Weller, Michael, Eisele, Günter
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595134/

Similar Items